INS and Hyperglycemia: Consistent with that, Hiroko et al. (3) had reported that treatment with a PKA inhibitor diminished S-Equol–mediated effects on β-cell proliferation and glucose-stimulated insulin secretion in streptozotocin-induced hyperglycemia rats, and oxidative stress (alloxan)-induced cell death.